Articles: health.
-
We report a case of mpox in an active duty male on board a naval warship, who presented with a chancre-like penile lesion and ulcerating lymphadenopathy in the setting of a nonreactive treponemal test. Despite empirical therapy for sexually transmitted infections, he developed a fever and a generalized pustular rash. ⋯ This case highlights the obligation of medical providers who care for our military personnel and veterans to offer JYNNEOS vaccine to high-risk individuals. Additionally, with the rise in clade I mpox cases prompting a recent global health emergency declaration by the World Health Organization, it is essential to implement proper testing methods and treatments when considering mpox in the differential diagnosis because of its association with other sexually transmitted infections.
-
Fit and healthy military personnel are the basis for a strong organization and good health care is essential to ensure service people's deployability. This applies equally to female-specific health care (FSH). Quality health care can help not only to recruit but also retain more women in the military. However, as there is a lack of empirical studies focusing on service women's experiences with FSH, this study explores female military personnel's experiences with FSH in the Netherlands Armed Forces (NAF), including conditions such as menstruation, pregnancy, and menopause in order to find ways of improving these women's health care and self-care. ⋯ The NAF are currently not focusing sufficiently on FSH. In order to provide their female personnel with a high quality of care, this will require changes in policy, implementation, and supervision as well as fostering the development of an open culture that enables discussions on FSH.
-
Anthrax, caused by the bacterium Bacillus anthracis, stands as a formidable threat with both natural and bioterrorism-related implications. Its ability to afflict a wide range of hosts, including humans and animals, coupled with its potential use as a bioweapon, underscores the critical importance of understanding and advancing our capabilities to combat this infectious disease. In this context, exploring futuristic approaches becomes imperative, as they hold the promise of not only addressing current challenges but also ushering in a new era in anthrax management. This review delves into strategies to mitigate the impact of anthrax on global health and security, envisioning a future where our arsenal against anthrax is characterized by precision and adaptability. ⋯ The upcoming advancements in anthrax research will be based on cutting-edge technologies and innovative approaches that demonstrate great potential for prevention, detection, and treatment. These advancements may include the incorporation of synthetic biology techniques such as precise manipulation of biological components, nanoscale diagnostics, and Clustered regularly interspaced short palindromic repeats-based technologies, which could revolutionize our ability to combat anthrax on a molecular level. As these progressive methodologies continue to evolve, the integration of these technologies has the potential to redefine our strategies against anthrax, providing more accurate, personalized, and adaptable approaches to address the challenges posed by this infectious threat.
-
We aimed to systematically investigate the associations between racial discrimination and various health outcomes and to evaluate the certainty of evidence from existing meta-analyses of observational studies. ⋯ Despite the complexity of measuring its impact, racial discrimination shows a profound influence across clinical areas, including an unexpected protective association in early-stage hepatocellular carcinoma diagnosis among Black patients.
-
Age at diagnosis of diabetes is important for informing public health planning and treatment strategies. This study aimed to estimate trends and racial/ethnic differences in age at diagnosis of adult-onset diabetes by type in the United States. ⋯ Among US adults, the mean age at diagnosis of adult-onset T1D remained stable and of adult-onset T2D increased significantly from 2016 to 2022. Substantial and opposite differences in mean diagnosis age of T1D and T2D by race/ethnicity were identified.